1.
Kim MJ, Kim BR, Kim SH, Chang YS, Youn SW. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients. Acta Derm Venereol [Internet]. 2023 Aug. 30 [cited 2024 Sep. 5];103:adv11627. Available from: https://medicaljournalssweden.se/actadv/article/view/11627